#DidYouKnow nearly 7 million Americans live with Alzheimer's Disease? An Alzheimer's diagnosis affects every aspect of a person's life, from their independence to relationships with loved ones and their financial stability. During #AlzheimersAwarenessMonth and every month, the Alector's work in Alzheimer's focuses on research, support, and advancements in treatment, highlighting ongoing projects and progress in the field. https://lnkd.in/gufATdBs
Alector
生物技术研究
South San Francisco,California 18,149 位关注者
We are harnessing the immune system to treat neurodegeneration and cancer.
关于我们
We have always walked our own path at Alector. That’s what led us to our bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.
- 网站
-
https://alector.com
Alector的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- South San Francisco,California
- 类型
- 上市公司
- 创立
- 2013
- 领域
- Biotechnology、Neurodegenerative disease、Neurodegeneration和Immuno-neurology
地点
-
主要
131 Oyster Point Blvd
Suite 600
US,California,South San Francisco,94080
Alector员工
动态
-
Brother/sister duo Jim and Myla recently visited Alector to share their moving story of caring for their mom, Betsy. Betsy was diagnosed with Mild Cognitive Impairment after having cared for her husband with Lewy Body Dementia. This year, she has progressed to Alzheimer’s Disease. Stories like Jim and Myla's serve as a tangible reminder of why we are committed to advancing therapies that alter the course of neurodegenerative disease. Thank you, Jim and Myla, for sharing your story with us.
-
We were honored to connect with #FTD patients and caregivers during the Penn Medicine, University of Pennsylvania Health System’s FTD Center annual Caregiver Conference yesterday. We are proud to sponsor Penn Medicine FTD Center's community events like this one, aimed to offer valuable insights into the latest dementia treatment advancements, diagnostics, and caregiving strategies to empower those impacted by #FTD. Thank you to the Penn FTD team for another impactful event!
-
The Alzheimer's Foundation of America Education America Tour for 2024 concludes with the last tour stop in Tulsa, OK. It’s an honor to sponsor this initiative and share valuable insights about #Alzheimers disease, brain health, and caregiving across the nation. A special thank you to the AFA team for their dedication to raising awareness and providing resources and support for families and caregivers affected by #Alzheimers.
-
Caregiving for a loved one can be a full-time, mentally, and emotionally taxing job. As an advocate and #dementia educator Katie Brandt says, "When you diagnose someone with dementia, you have two patients: the person living with the disease and their caregiver. Both require your support." November is National #FamilyCaregiversMonth. Because there is so much on their plate, many caregivers don’t spend time taking care of themselves. Caring for yourself promotes care for your loved one. Learn more today from the National Institute on Aging (NIA): https://lnkd.in/gF9jJd4v
-
November is #AlzheimersAwarenessMonth. To the millions of people affected by this devastating disease and their loved ones: we see you, we hear you, and we are committed to bringing new treatment options to you. For resources & support, visit advocacy groups like the Alzheimer's Foundation of America. Thank you to all the #Alzheimers advocacy groups committed to raising awareness about this devastating disease.
-
The Alector team traveled to Madrid for #CTAD24! We've enjoyed a productive week connecting with industry peers and key leaders in #Alzheimers research. Thank you, CTAD Clinical Trials on Alzheimer's Disease, for another successful meeting!
-
We're thrilled to share that we are officially certified as a #GPTW2024 for a fourth consecutive year! This achievement highlights the strong community we cultivate at Alector - a culture where innovation thrives, and our people feel empowered to make a real impact. We're grateful for Alectorians' passion, hard work, and unwavering commitment to getting new medicines to people living with dementia and their families.
-
"In my years working as a research nurse, I witnessed firsthand the despair that can come when no treatments are available or when one has exhausted all standard treatments. Research provides hope to families." Grace Mausisa, Patient Engagement Lead, says of her career journey to working in biotech. She shares more about the impact of her work at Alector below.